Oxycinchophen

Oxycinchophen
Clinical data

ATC code	M01CA03 (WHO)
Identifiers
IUPAC name 3-hydroxy-2-phenylquinoline-4-carboxylic acid
PubChem (CID)	10239
ChemSpider	9822^N
UNII	UK6392GD5W^Y
KEGG	D07271^Y
ECHA InfoCard	100.006.932
Chemical and physical data
Formula	C₁₆H₁₁NO₃
Molar mass	265.26344 g/mol
3D model (Jmol)	Interactive image
SMILES O=C(O)c1c3ccccc3nc(c1O)c2ccccc2
InChI InChI=1S/C16H11NO3/c18-15-13(16(19)20)11-8-4-5-9-12(11)17-14(15)10-6-2-1-3-7-10/h1-9,18H,(H,19,20)^N Key:XAPRFLSJBSXESP-UHFFFAOYSA-N^N
^NY (what is this?) (verify)

Oxycinchophen is an antirheumatic agent.^[1]^[2]

References

↑ Iversen, M.; Munck, J.; Schourup, K. (1953). "On the toxicity of 3-hydroxy-2-phenylcinchoninic acid (oxycinchophen); histo-pathological studies in rabbits and guinea-pigs". Acta pharmacologica et toxicologica. 9 (3): 215–219. doi:10.1111/j.1600-0773.1953.tb02948.x. PMID 13123940.
↑ US 2776290 issued in 1957 to Chemo Puro).

Specific antirheumatic products / DMARDs (M01C)

Quinolines	Oxycinchophen

Gold preparations	Sodium aurothiomalate Sodium aurothiosulfate Auranofin Aurothioglucose Aurotioprol

Other	Penicillamine #/Bucillamine Chloroquine #/Hydroxychloroquine Leflunomide Sulfasalazine # antifolate (Methotrexate #) thiopurine (Azathioprine) #

^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

This article is issued from Wikipedia - version of the 5/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.